Genomic analysis of reduced susceptibility to Tigecycline in Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 239-244

  Cattoir, Vincent ^a,b,c   Isnard, Christophe ^a,b   Cosquer, Thibaud ^a   Odhiambo, Arlène ^a   Bucquet, Fiona ^a   Guérin, François ^a,b,c   Giard, Jean Christophe ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c Centre National de Référence sur la Résistance aux Antibiotiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMPICILLIN; BACTERIAL DNA; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; GENTAMICIN; LINEZOLID; MINOCYCLINE; PANTOPRAZOLE; RESERPINE; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; RIBOSOME PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; DELETION MUTANT; ENTEROCOCCUS FAECIUM; GENE MUTATION; GENOME ANALYSIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MUTATION;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; GENOME, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MUTATION; RIBOSOMAL PROTEINS; TETRACYCLINE RESISTANCE;

EID: 84920121702     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04174-14     Document Type: Article

References (30)

1. Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10:266-278. http://dx.doi.org/10.1038/nrmicro2761.
2. Top J, Willems R, Bonten M. 2008. Emergence of CC17 Enterococcus faecium from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 52:297-308. http://dx.doi.org/10.1111/j.1574-695X.2008.00383.x.
3. Cattoir V, Giard JC. 2014. Antibiotic resistance in Enterococcus faecium clinical isolates. Expert Rev Anti Infect Ther 12:239-248. http://dx.doi.org/10.1586/14787210.2014.870886.
4. Noskin GA. 2005. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 41:S303-S314. http://dx.doi.org/10.1086/431672.
5. Wenzel R, Bate G, Kirkpatrick P. 2005. Tigecycline. Nat Rev Drug Discov 4:809-810. http://dx.doi.org/10.1038/nrd1857.
6. Bauer G, Berens C, Projan SJ, Hillen W. 2004. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA. J Antimicrob. Chemother 53:592-599. http://dx.doi.org/10.1093/jac/dkh125.
7. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61:46-53. http://dx.doi.org/10.1093/jac/dkm397.
8. Sun Y, Cai Y, Liu X, Bai N, Liang B, Wang R. 2013. The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents 41:110-116. http://dx.doi.org/10.1016/j.ijantimicag.2012.09.005.
9. Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T. 2012. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 56:4450-4458. http://dx.doi.org/10.1128/AAC.00456-12.
10. McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, Bradford PA. 2005. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 49:1865-1871. http://dx.doi.org/10.1128/AAC.49.5.1865-1871.2005.
11. Werner G, Gfrörer S, Fleige C, Witte W, Klare I. 2008. Tigecyclineresistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 61:1182-1183. http://dx.doi.org/10.1093/jac/dkn065.
12. Freitas AR, Novais C, Correia R, Monteiro M, Coque TM, Peixe L. 2011. Non-susceptibility to tigecycline in enterococci from hospitalised patients, food products and community sources. Int J Antimicrob Agents 38:174-176. http://dx.doi.org/10.1016/j.ijantimicag.2011.04.014.
13. Cattoir V, Bucquet F, Giard J-C. 2014. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium, abstr. C-843. Abstr 54th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC.
14. Lam MM, Seemann T, Bulach DM, Gladman SL, Chen H, Haring V, Moore RJ, Ballard S, Grayson ML, Johnson PD, Howden BP, Stinear TP. 2012. Comparative analysis of the first complete Enterococcus faecium genome. J Bacteriol 194:2334-2341. http://dx.doi.org/10.1128/JB.00259-12.
15. Bozdogan B, Leclercq R. 1999. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob Agents Chemother 43:2720-2725.
16. Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, Dabrowska M, Venema G, Kok J. 1996. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 253:217-224. http://dx.doi.org/10.1007/s004380050315.
17. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; approved standard, 23rd ed, M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Ahmed M, Borsch CM, Neyfakh AA, Schuldiner S. 1993. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J Biol Chem 268:11086-11089.
19. Lebreton F, van Schaik W, Sanguinetti M, Posteraro B, Torelli R, Le Bras F, Verneuil N, Zhang X, Giard JC, Dhalluin A, Willems RJ, Leclercq R, Cattoir V. 2012. AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLoS Pathog 8:e1002834. http://dx.doi.org/10.1371/journal.ppat.1002834.
20. Zhang X, Vrijenhoek JE, Bonten MJ, Willems RJ, van Schaik W. 2011. Agenetic element present on megaplasmids allows Enterococcus faecium to use raffinose as carbon source. Environ Microbiol 13:518-528. http://dx.doi.org/10.1111/j.1462-2920.2010.02355.x.
21. Poyart C. 2010. Tetracyclines, p 327-337. In Courvalin P, Leclercq R, Rice LB (ed), Antibiogram. ASM Press, Washington, DC.
22. Nishimoto Y, Kobayashi N, Alam MM, Ishino M, Uehara N, Watanabe N. 2005. Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb Drug Resist 11:146-153. http://dx.doi.org/10.1089/mdr.2005.11.146.
23. Stein GE, Babinchak T. 2013. Tigecycline: an update. Diagn Microbiol Infect Dis 75:331-336. http://dx.doi.org/10.1016/j.diagmicrobio.2012.12 .004.
24. Tubau F, Liñares J, Rodríguez MD, Cercenado E, Aldea MJ, González- Romo F, Torroba L, Berdonces P, Plazas J, Aguilar L, Delgado A, García-Escribano N, Study Group. 2010. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Diagn Microbiol Infect Dis 66:308-313. http://dx.doi.org/10.1016/j.diagmicrobio.2009.10.018.
25. Kanj SS, Whitelaw A, Dowzicky MJ. 2014. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011. Int J Antimicrob Agents 43:170-178. http://dx.doi.org/10.1016/j.ijantimicag.2013.10.011.
26. Luo X, Hsiao HH, Bubunenko M, Weber G, Court DL, Gottesman ME, Urlaub H, Wahl MC. 2008. Structural and functional analysis of the E. coli NusB-S10 transcription antitermination complex. Mol Cell 32:791-802. http://dx.doi.org/10.1016/j.molcel.2008.10.028.
27. Weisberg RA. 2008. Transcription by moonlight: structural basis of an extraribosomal activity of ribosomal protein S10. Mol Cell 32:747-748. http://dx.doi.org/10.1016/j.molcel.2008.12.010.
28. Villa L, Feudi C, Fortini D, García-Fernández A, Carattoli A. 2014. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother 58: 1707-1712. http://dx.doi.org/10.1128/AAC.01803-13.
29. Hu M, Nandi S, Davies C, Nicholas RA. 2005. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Chemother 49:4327-4334. http://dx.doi.org/10.1128/AAC.49.10.4327-4334.2005.
30. Williams G, Smith I. 1979. Chromosomal mutations causing resistance to tetracycline in Bacillus subtilis. Mol Gen Genet 177:23-29. http://dx.doi.org/10.1007/BF00267249.